[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Autoimmune Disease Therapeutics Market Analysis 2016-2020 and Forecast 2021-2026

March 2021 | 86 pages | ID: G8C8C5E679CEN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

The global Autoimmune Disease Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Autoimmune Disease Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Immunosuppressants
  • Anti-Inflammatory Drugs
  • Corticosteroids
  • Nonsteroidal Anti-inflammatory Drugs
  • Biologics
  • Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Pfizer
  • Novartis
  • Johnson & Johnson Services
  • Merck
  • Sanofi
  • Abott
  • Bristol-Myers Squibb
  • Amgen
  • Bayer
  • F. Hoffmann-La Roche
  • Eli Lilly and Company
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Hospitals
  • Clinics
  • Independent Pharmacies
  • Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Autoimmune Disease Therapeutics Industry
Figure Autoimmune Disease Therapeutics Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Autoimmune Disease Therapeutics
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Autoimmune Disease Therapeutics
  1.2.2 Downstream
Table Application Segment of Autoimmune Disease Therapeutics
Table Global Autoimmune Disease Therapeutics Market 2016-2026, by Application, in USD Million
  1.2.3 COVID-19 Impact
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY TYPE

3.1 By Type
  3.1.1 Immunosuppressants
Table Major Company List of Immunosuppressants
  3.1.2 Anti-Inflammatory Drugs
Table Major Company List of Anti-Inflammatory Drugs
  3.1.3 Corticosteroids
Table Major Company List of Corticosteroids
  3.1.4 Nonsteroidal Anti-inflammatory Drugs
Table Major Company List of Nonsteroidal Anti-inflammatory Drugs
  3.1.5 Biologics
Table Major Company List of Biologics
  3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Type, in USD Million
Figure Global Autoimmune Disease Therapeutics Market Growth 2016-2020, by Type, in USD Million
Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Type, in Volume
Figure Global Autoimmune Disease Therapeutics Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Type, in USD Million
Table Global Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 Pfizer (Company Profile, Sales Data etc.)
  4.1.1 Pfizer Profile
Table Pfizer Overview List
  4.1.2 Pfizer Products & Services
  4.1.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Novartis (Company Profile, Sales Data etc.)
  4.2.1 Novartis Profile
Table Novartis Overview List
  4.2.2 Novartis Products & Services
  4.2.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Johnson & Johnson Services (Company Profile, Sales Data etc.)
  4.3.1 Johnson & Johnson Services Profile
Table Johnson & Johnson Services Overview List
  4.3.2 Johnson & Johnson Services Products & Services
  4.3.3 Johnson & Johnson Services Business Operation Conditions
Table Business Operation of Johnson & Johnson Services (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Merck (Company Profile, Sales Data etc.)
  4.4.1 Merck Profile
Table Merck Overview List
  4.4.2 Merck Products & Services
  4.4.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Sanofi (Company Profile, Sales Data etc.)
  4.5.1 Sanofi Profile
Table Sanofi Overview List
  4.5.2 Sanofi Products & Services
  4.5.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Abott (Company Profile, Sales Data etc.)
  4.6.1 Abott Profile
Table Abott Overview List
  4.6.2 Abott Products & Services
  4.6.3 Abott Business Operation Conditions
Table Business Operation of Abott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
  4.7.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
  4.7.2 Bristol-Myers Squibb Products & Services
  4.7.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Amgen (Company Profile, Sales Data etc.)
  4.8.1 Amgen Profile
Table Amgen Overview List
  4.8.2 Amgen Products & Services
  4.8.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Bayer (Company Profile, Sales Data etc.)
  4.9.1 Bayer Profile
Table Bayer Overview List
  4.9.2 Bayer Products & Services
  4.9.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
  4.10.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
  4.10.2 F. Hoffmann-La Roche Products & Services
  4.10.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Eli Lilly and Company (Company Profile, Sales Data etc.)
  4.11.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
  4.11.2 Eli Lilly and Company Products & Services
  4.11.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Autoimmune Disease Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
Table Global Autoimmune Disease Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Autoimmune Disease Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
Table Global Autoimmune Disease Therapeutics Sales Volume 2016-2020, by Company, in Volume
Table Global Autoimmune Disease Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Autoimmune Disease Therapeutics Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Autoimmune Disease Therapeutics Market Concentration, in 2020
Figure Europe Autoimmune Disease Therapeutics Market Market Concentration, in 2020
Figure Asia-Pacific Autoimmune Disease Therapeutics MMarket Concentration, in 2020
Figure South America Autoimmune Disease Therapeutics Market Concentration, in 2020
Figure Middle East & Africa Autoimmune Disease Therapeutics Market Concentration, in 2020

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Hospitals
Figure Autoimmune Disease Therapeutics Demand in Hospitals , 2016-2020, in USD Million
Figure Autoimmune Disease Therapeutics Demand in Hospitals , 2016-2020, in Volume
  6.1.2 Demand in Clinics
Figure Autoimmune Disease Therapeutics Demand in Clinics , 2016-2020, in USD Million
Figure Autoimmune Disease Therapeutics Demand in Clinics , 2016-2020, in Volume
  6.1.3 Demand in Independent Pharmacies
Figure Autoimmune Disease Therapeutics Demand in Independent Pharmacies , 2016-2020, in USD Million
Figure Autoimmune Disease Therapeutics Demand in Independent Pharmacies , 2016-2020, in Volume
  6.1.4 Demand in Others
Figure Autoimmune Disease Therapeutics Demand in Others, 2016-2020, in USD Million
Figure Autoimmune Disease Therapeutics Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Autoimmune Disease Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
Figure Autoimmune Disease Therapeutics Market Growth 2021-2026, by Application, in USD Million
Figure Autoimmune Disease Therapeutics Market Share in 2026, by Application, in USD Million
Table Autoimmune Disease Therapeutics Demand Forecast 2021-2026, by Application, in Volume
Table Autoimmune Disease Therapeutics Market Growth 2021-2026, by Application, in Volume
Table Autoimmune Disease Therapeutics Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand

7 REGION OPERATION

7.1 Regional Production
Table Autoimmune Disease Therapeutics Production 2016-2020, by Region, in USD Million
Table Autoimmune Disease Therapeutics Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Region, in USD Million
Table Global Autoimmune Disease Therapeutics Market Share 2016-2020, by Region, in USD Million
Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Region, in Volume
Table Global Autoimmune Disease Therapeutics Market Share 2016-2020, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure North America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
Table North America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Europe Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Europe Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure South America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
Table South America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Region, in USD Million
Table Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Autoimmune Disease Therapeutics
2. Table Application Segment of Autoimmune Disease Therapeutics
3. Table Global Autoimmune Disease Therapeutics Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Anti-Inflammatory Drugs 
5. Table Major Company List of Corticosteroids 
6. Table Major Company List of Nonsteroidal Anti-inflammatory Drugs 
7. Table Major Company List of Biologics 
8. Table Major Company List of Others
9. Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Type, in USD Million
10. Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Type, in Volume
11. Table Global Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Type, in USD Million
12. Table Global Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Type, in Volume
13. Table Pfizer  Overview List
14. Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Novartis  Overview List
16. Table Business Operation of Novartis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Johnson & Johnson Services  Overview List
18. Table Business Operation of Johnson & Johnson Services  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Merck  Overview List
20. Table Business Operation of Merck  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Sanofi  Overview List
22. Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Abott  Overview List
24. Table Business Operation of Abott  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Bristol-Myers Squibb  Overview List
26. Table Business Operation of Bristol-Myers Squibb  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Amgen  Overview List
28. Table Business Operation of Amgen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Bayer  Overview List
30. Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table F. Hoffmann-La Roche  Overview List
32. Table Business Operation of F. Hoffmann-La Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Eli Lilly and Company Overview List
34. Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
35. Table Global Autoimmune Disease Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
36. Table Global Autoimmune Disease Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
37. Table Global Autoimmune Disease Therapeutics Sales Volume 2016-2020, by Company, in Volume
38. Table Global Autoimmune Disease Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
39. Table Regional Demand Comparison List
40. Table Major Application in Different Regions
41. Table Autoimmune Disease Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
42. Table Autoimmune Disease Therapeutics Demand Forecast 2021-2026, by Application, in Volume
43. Table Autoimmune Disease Therapeutics Market Growth 2021-2026, by Application, in Volume
44. Table Autoimmune Disease Therapeutics Market Share in 2026, by Application, in Volume
45. Table Autoimmune Disease Therapeutics Production 2016-2020, by Region, in USD Million
46. Table Autoimmune Disease Therapeutics Production 2016-2020, by Region, in Volume
47. Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Region, in USD Million
48. Table Global Autoimmune Disease Therapeutics Market Share 2016-2020, by Region, in USD Million
49. Table Global Autoimmune Disease Therapeutics Market 2016-2020, by Region, in Volume
50. Table Global Autoimmune Disease Therapeutics Market Share 2016-2020, by Region, in Volume
51. Table North America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
52. Table North America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
53. Table Europe Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
54. Table Europe Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
55. Table Asia-Pacific Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
56. Table Asia-Pacific Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
57. Table South America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
58. Table South America Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
59. Table Middle East & Africa Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in USD Million
60. Table Middle East & Africa Autoimmune Disease Therapeutics Market Size 2016-2020, by Country, in Volume
61. Table Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Region, in USD Million
62. Table Autoimmune Disease Therapeutics Market Forecast 2021-2026, by Region, in Volume
63. Table Price Factors List
LIST OF FIGURES
1. Figure Autoimmune Disease Therapeutics Industry Chain Structure
2. Figure Global Autoimmune Disease Therapeutics Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Autoimmune Disease Therapeutics Market Growth 2016-2020, by Type, in Volume
4. Figure Global Autoimmune Disease Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Autoimmune Disease Therapeutics Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Autoimmune Disease Therapeutics Market Concentration, in 2020
7. Figure Europe Autoimmune Disease Therapeutics Market Market Concentration, in 2020
8. Figure Asia-Pacific Autoimmune Disease Therapeutics MMarket Concentration, in 2020
9. Figure South America Autoimmune Disease Therapeutics Market Concentration, in 2020
10. Figure Middle East & Africa Autoimmune Disease Therapeutics Market Concentration, in 2020
11. Figure Autoimmune Disease Therapeutics Demand in Hospitals , 2016-2020, in USD Million
12. Figure Autoimmune Disease Therapeutics Demand in Hospitals , 2016-2020, in Volume
13. Figure Autoimmune Disease Therapeutics Demand in Clinics , 2016-2020, in USD Million
14. Figure Autoimmune Disease Therapeutics Demand in Clinics , 2016-2020, in Volume
15. Figure Autoimmune Disease Therapeutics Demand in Independent Pharmacies , 2016-2020, in USD Million
16. Figure Autoimmune Disease Therapeutics Demand in Independent Pharmacies , 2016-2020, in Volume
17. Figure Autoimmune Disease Therapeutics Demand in Others, 2016-2020, in USD Million
18. Figure Autoimmune Disease Therapeutics Demand in Others, 2016-2020, in Volume
19. Figure Autoimmune Disease Therapeutics Market Growth 2021-2026, by Application, in USD Million
20. Figure Autoimmune Disease Therapeutics Market Share in 2026, by Application, in USD Million
21. Figure North America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
22. Figure North America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
23. Figure Europe Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
24. Figure Europe Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
25. Figure Asia-Pacific Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
26. Figure Asia-Pacific Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
27. Figure South America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
28. Figure South America Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
29. Figure Middle East & Africa Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in USD Million
30. Figure Middle East & Africa Autoimmune Disease Therapeutics Market Size and Growth 2016-2020, in Volume
31. Figure Marketing Channels Overview


More Publications